Hui‐Hui Lin

937 citations
52 papers · 662 · h-index 16

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Epigenetics and DNA Methylation
    • Circular RNAs in diseases
    • RNA modifications and cancer

Papers in

    • Epigenetics and DNA Methylation 7
    • Circular RNAs in diseases 5
    • Bladder and Urothelial Cancer Treatments 14

Hui‐Hui Lin

48 papers receiving 656 citations

Peers

Hui‐Hui Lin
Comparison fields: 5 of 82
  • Cancer Research 165
  • Molecular Biology 337
  • Surgery 205
  • Oncology 110
  • Obstetrics and Gynecology 28
Replace Xiaoyan Ding with:
Xiaoyan Ding China
Qi You China
Liangyu Bie China
Xin Zhu China
Tongzu Liu China
Atsushi Kawabe Japan
Hang Lv China
Seiji Arai Japan
Hui‐Hui Lin relative to Xiaoyan Ding China Xiaoyan Ding's profile →
Citations per field
00.5×
Xiaoyan Ding · 1×
Citations per year

Countries citing papers authored by Hui‐Hui Lin

Since Specialization
Citations

This map shows the geographic impact of Hui‐Hui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Hui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Hui Lin more than expected).

Fields of papers citing papers by Hui‐Hui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Hui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Hui Lin. The network helps show where Hui‐Hui Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Hui‐Hui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hui‐Hui Lin Line = papers co-authored together Hui‐Hui Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200954
2 201735
3 201334
4 201632
5 201529
6 199729
7 201427
8 201026
9 201925
10 200924
11 200723
12 201023
13 202022
14 201822
15
Cyclooxygenase-2 (COX-2) up-regulation is a prognostic marker for poor clinical outcome of upper tract urothelial cancer.
201220
16
Association of cyclooxygenase 2 polymorphic genotypes with prostate cancer in taiwan.
201118
17 201715
18
The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
201215
19 202414
20 201913

About Hui‐Hui Lin

Hui‐Hui Lin is a scholar working on Molecular Biology, Surgery, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 52 papers that have together received 662 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), MicroRNA in disease regulation (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (7 papers), Cancer, Lipids, and Metabolism (5 papers), Circular RNAs in diseases (5 papers), Genetic factors in colorectal cancer (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Cancer Research (165 citations), Molecular Biology (337 citations), Surgery (205 citations), Oncology (110 citations) and Obstetrics and Gynecology (28 citations). Hui‐Hui Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Jeng Wu, Hung‐Lung Ke, Lin‐Li Chang, Hsin‐Chih Yeh, Wei‐Ming Li, Shu‐Pin Huang, A‐Mei Huang, Ching‐Chia Li, Yi‐Chen Lee and Sheau‐Fang Yang. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, International Journal of Medical Sciences, British Journal of Urology, Toxicology and Industrial Health and Lung.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact